Share & more
A partnership between Uganda's Quality Chemicals and Indian drug manufacturer Cipla will make anti-AIDS drugs more affordable for HIV-positive Ugandans.
The managing director of Quality Chemicals, Emmanuel Katongole, said AIDS-related illness mostly claimed the lives of poor people because they could not afford the high cost of antiretrovirals, and even a 50 percent reduction in prices would mean a 100 percent increase in number of people receiving treatment.
A local newspaper, The Monitor, quoted Katongole as saying: "We promise to continue [assisting all] people pushing for lower prices of antiretrovirals until it's affordable to all who need them."
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions